vs
John Marshall Bancorp, Inc.（JMSB）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是John Marshall Bancorp, Inc.的1.2倍（$19.6M vs $16.8M），John Marshall Bancorp, Inc.净利率更高（36.3% vs -177.4%，领先213.7%），过去两年John Marshall Bancorp, Inc.的营收复合增速更高（15.3% vs -12.2%）
约翰·马歇尔银行控股公司是一家总部位于美国的银行控股企业，通过旗下全资子公司约翰·马歇尔银行开展业务，提供商业及零售银行服务，包括存款、商业贷款、住房抵押贷款等，主要服务美国大西洋中部地区的零售客户和中小微企业。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
JMSB vs LAB — 直观对比
营收规模更大
LAB
是对方的1.2倍
$16.8M
净利率更高
JMSB
高出213.7%
-177.4%
两年增速更快
JMSB
近两年复合增速
-12.2%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.8M | $19.6M |
| 净利润 | $6.1M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | — | -168.5% |
| 净利率 | 36.3% | -177.4% |
| 营收同比 | — | -11.5% |
| 净利润同比 | 26.8% | -28.8% |
| 每股收益（稀释后） | $0.43 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JMSBLAB
| Q1 26 | $16.8M | — | ||
| Q4 25 | $16.4M | — | ||
| Q3 25 | $16.3M | $19.6M | ||
| Q2 25 | $15.4M | $21.8M | ||
| Q1 25 | $14.6M | $40.8M | ||
| Q4 24 | $14.3M | — | ||
| Q3 24 | $13.8M | $22.1M | ||
| Q2 24 | $12.6M | $22.5M |
净利润JMSBLAB
| Q1 26 | $6.1M | — | ||
| Q4 25 | $5.9M | — | ||
| Q3 25 | $5.4M | $-34.7M | ||
| Q2 25 | $5.1M | $-33.5M | ||
| Q1 25 | $4.8M | $-26.0M | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $4.2M | $-26.9M | ||
| Q2 24 | $3.9M | $-45.7M |
毛利率JMSBLAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% |
营业利润率JMSBLAB
| Q1 26 | — | — | ||
| Q4 25 | 47.4% | — | ||
| Q3 25 | 42.2% | -168.5% | ||
| Q2 25 | 42.7% | -118.1% | ||
| Q1 25 | 42.4% | -80.8% | ||
| Q4 24 | 42.5% | — | ||
| Q3 24 | 38.8% | -120.9% | ||
| Q2 24 | 39.7% | -134.5% |
净利率JMSBLAB
| Q1 26 | 36.3% | — | ||
| Q4 25 | 36.2% | — | ||
| Q3 25 | 33.2% | -177.4% | ||
| Q2 25 | 33.1% | -153.7% | ||
| Q1 25 | 32.9% | -63.8% | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 30.7% | -122.0% | ||
| Q2 24 | 30.9% | -203.3% |
每股收益（稀释后）JMSBLAB
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.41 | — | ||
| Q3 25 | $0.38 | $-0.09 | ||
| Q2 25 | $0.36 | $-0.09 | ||
| Q1 25 | $0.34 | $-0.07 | ||
| Q4 24 | $0.33 | — | ||
| Q3 24 | $0.30 | $-0.07 | ||
| Q2 24 | $0.27 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $150.2M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $268.1M | $399.7M |
| 总资产 | $2.4B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资JMSBLAB
| Q1 26 | $150.2M | — | ||
| Q4 25 | $130.0M | — | ||
| Q3 25 | $163.6M | $129.4M | ||
| Q2 25 | $116.9M | $158.6M | ||
| Q1 25 | $169.1M | $150.9M | ||
| Q4 24 | $122.5M | — | ||
| Q3 24 | $177.2M | $210.6M | ||
| Q2 24 | $182.6M | $269.8M |
总债务JMSBLAB
| Q1 26 | — | — | ||
| Q4 25 | $80.9M | — | ||
| Q3 25 | $80.9M | — | ||
| Q2 25 | $80.8M | — | ||
| Q1 25 | $80.8M | — | ||
| Q4 24 | $80.8M | — | ||
| Q3 24 | $80.8M | $55.2M | ||
| Q2 24 | $24.7M | $55.1M |
股东权益JMSBLAB
| Q1 26 | $268.1M | — | ||
| Q4 25 | $265.6M | — | ||
| Q3 25 | $259.7M | $399.7M | ||
| Q2 25 | $253.7M | $424.5M | ||
| Q1 25 | $253.0M | $454.6M | ||
| Q4 24 | $246.6M | — | ||
| Q3 24 | $243.1M | $489.3M | ||
| Q2 24 | $235.3M | $510.3M |
总资产JMSBLAB
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | $539.6M | ||
| Q2 25 | $2.3B | $557.0M | ||
| Q1 25 | $2.3B | $579.6M | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.3B | $681.5M | ||
| Q2 24 | $2.3B | $708.7M |
负债/权益比JMSBLAB
| Q1 26 | — | — | ||
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | 0.32× | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 0.33× | 0.11× | ||
| Q2 24 | 0.11× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流JMSBLAB
| Q1 26 | — | — | ||
| Q4 25 | $22.6M | — | ||
| Q3 25 | $1.2M | $-22.2M | ||
| Q2 25 | $7.5M | $-20.7M | ||
| Q1 25 | $7.0M | $-30.3M | ||
| Q4 24 | $17.3M | — | ||
| Q3 24 | $1.4M | $-27.9M | ||
| Q2 24 | $10.2M | $-39.0M |
自由现金流JMSBLAB
| Q1 26 | — | — | ||
| Q4 25 | $22.0M | — | ||
| Q3 25 | $1.2M | $-23.1M | ||
| Q2 25 | $7.4M | $-22.6M | ||
| Q1 25 | $6.6M | $-35.3M | ||
| Q4 24 | $16.8M | — | ||
| Q3 24 | $1.3M | $-30.1M | ||
| Q2 24 | $10.1M | $-41.0M |
自由现金流率JMSBLAB
| Q1 26 | — | — | ||
| Q4 25 | 134.7% | — | ||
| Q3 25 | 7.3% | -118.1% | ||
| Q2 25 | 47.8% | -103.6% | ||
| Q1 25 | 45.3% | -86.6% | ||
| Q4 24 | 116.9% | — | ||
| Q3 24 | 9.5% | -136.4% | ||
| Q2 24 | 80.1% | -182.2% |
资本支出强度JMSBLAB
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | — | ||
| Q3 25 | 0.2% | 4.5% | ||
| Q2 25 | 1.0% | 8.7% | ||
| Q1 25 | 2.3% | 12.4% | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 0.8% | 10.2% | ||
| Q2 24 | 0.4% | 8.6% |
现金转化率JMSBLAB
| Q1 26 | — | — | ||
| Q4 25 | 3.82× | — | ||
| Q3 25 | 0.23× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 1.45× | — | ||
| Q4 24 | 3.61× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 2.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JMSB
| Net Interest Income | $16.5M | 98% |
| Noninterest Income | $284.0K | 2% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
